While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...

New medicines, access to treatments, infectious disease monitoring, and more are on the table. View on euronews ...

Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's best to discuss with your doctor first.

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...

Praxis recognized $0.3 million in collaboration revenue during the three months ended September 30, 2024, compared to $0.5 million during the three months ended September 30, 2023. The decrease of ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...

Apple is set to be fined by the European Union's antitrust regulators under the bloc's landmark rules aimed at reining in the ...